865 related articles for article (PubMed ID: 27882473)
1. Foxp3, Regulatory T Cell, and Autoimmune Diseases.
Tao JH; Cheng M; Tang JP; Liu Q; Pan F; Li XP
Inflammation; 2017 Feb; 40(1):328-339. PubMed ID: 27882473
[TBL] [Abstract][Full Text] [Related]
2. The role of FOXP3
Mohr A; Atif M; Balderas R; Gorochov G; Miyara M
Clin Exp Immunol; 2019 Jul; 197(1):24-35. PubMed ID: 30830965
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T cell metabolism at the intersection between autoimmune diseases and cancer.
Kurniawan H; Soriano-Baguet L; Brenner D
Eur J Immunol; 2020 Nov; 50(11):1626-1642. PubMed ID: 33067808
[TBL] [Abstract][Full Text] [Related]
4. Impact of CD4+CD25high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus.
Atfy M; Amr GE; Elnaggar AM; Labib HA; Esh A; Elokely AM
Egypt J Immunol; 2009; 16(1):117-26. PubMed ID: 20726328
[TBL] [Abstract][Full Text] [Related]
5. FoxP3
Saleh R; Elkord E
Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551
[TBL] [Abstract][Full Text] [Related]
6. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
[TBL] [Abstract][Full Text] [Related]
7. CD4(+)FoxP3(+) regulatory T-cells in human systemic lupus erythematosus.
Suen JL; Chiang BL
J Formos Med Assoc; 2012 Sep; 111(9):465-70. PubMed ID: 23021502
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Variability of CD4+CD25+ Tregs Contributes to the Pathogenesis of Autoimmune Diseases.
Shu Y; Hu Q; Long H; Chang C; Lu Q; Xiao R
Clin Rev Allergy Immunol; 2017 Apr; 52(2):260-272. PubMed ID: 27687891
[TBL] [Abstract][Full Text] [Related]
9. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
Peterson LB; Bell CJM; Howlett SK; Pekalski ML; Brady K; Hinton H; Sauter D; Todd JA; Umana P; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Klein C; Hosse RJ; Wicker LS
J Autoimmun; 2018 Dec; 95():1-14. PubMed ID: 30446251
[TBL] [Abstract][Full Text] [Related]
10. Imbalance of regulatory T cells in human autoimmune diseases.
Dejaco C; Duftner C; Grubeck-Loebenstein B; Schirmer M
Immunology; 2006 Mar; 117(3):289-300. PubMed ID: 16476048
[TBL] [Abstract][Full Text] [Related]
11. Harnessing regulatory T cells for the therapy of lupus and other autoimmune diseases.
Sharabi A; Mozes E
Immunotherapy; 2009 May; 1(3):385-401. PubMed ID: 20635958
[TBL] [Abstract][Full Text] [Related]
12. mTOR signaling, Tregs and immune modulation.
Chapman NM; Chi H
Immunotherapy; 2014; 6(12):1295-311. PubMed ID: 25524385
[TBL] [Abstract][Full Text] [Related]
13. Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp
Ferreira RC; Castro Dopico X; Oliveira JJ; Rainbow DB; Yang JH; Trzupek D; Todd SA; McNeill M; Steri M; Orrù V; Fiorillo E; Crouch DJM; Pekalski ML; Cucca F; Tree TI; Vyse TJ; Wicker LS; Todd JA
Front Immunol; 2019; 10():2606. PubMed ID: 31781109
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T cells in systemic lupus erythematosus.
Ohl K; Tenbrock K
Eur J Immunol; 2015 Feb; 45(2):344-55. PubMed ID: 25378177
[TBL] [Abstract][Full Text] [Related]
15. Forkhead box protein 3: essential immune regulatory role.
Nik Tavakoli N; Hambly BD; Sullivan DR; Bao S
Int J Biochem Cell Biol; 2008; 40(11):2369-73. PubMed ID: 18037337
[TBL] [Abstract][Full Text] [Related]
16. Functional Defects of Treg Cells: New Targets in Rheumatic Diseases, Including Ankylosing Spondylitis.
Miao J; Zhu P
Curr Rheumatol Rep; 2018 Apr; 20(5):30. PubMed ID: 29663162
[TBL] [Abstract][Full Text] [Related]
17. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
[TBL] [Abstract][Full Text] [Related]
18. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
[TBL] [Abstract][Full Text] [Related]
19. Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns.
Miyara M; Sakaguchi S
Immunol Cell Biol; 2011 Mar; 89(3):346-51. PubMed ID: 21301480
[TBL] [Abstract][Full Text] [Related]
20.
Lawless OJ; Bellanti JA; Brown ML; Sandberg K; Umans JG; Zhou L; Chen W; Wang J; Wang K; Zheng SG
Allergy Asthma Proc; 2018 Mar; 39(2):143-152. PubMed ID: 29490770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
